Cite
HARVARD Citation
Bewersdorf, J. et al. (2021). Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant. Leukemia & lymphoma. 62 (14), pp. 3394-3401. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bewersdorf, J. et al. (2021). Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant. Leukemia & lymphoma. 62 (14), pp. 3394-3401. [Online].